Kerbauy M, Rocha F, Arcuri L, Cunegundes P, Kerbauy L, Machado C
Haematologica. 2024; 110(3):640-650.
PMID: 39279428
PMC: 11873711.
DOI: 10.3324/haematol.2024.285921.
van der Ploeg K, Sottile R, Kontopoulos T, Shaffer B, Papanicolaou G, Maloy M
Blood Adv. 2023; 7(19):5784-5798.
PMID: 37196646
PMC: 10561005.
DOI: 10.1182/bloodadvances.2022008952.
Mushtaq M, Shahzad M, Shah A, Chaudhary S, Zafar M, Anwar I
Front Immunol. 2022; 13:1005031.
PMID: 36263054
PMC: 9574024.
DOI: 10.3389/fimmu.2022.1005031.
Damele L, Spaggiari G, Parodi M, Mingari M, Vitale M, Vitale C
Cancers (Basel). 2022; 14(18).
PMID: 36139598
PMC: 9496735.
DOI: 10.3390/cancers14184439.
Zhao X, Cai L, Hu Y, Wang H
Front Immunol. 2020; 11:584099.
PMID: 33193399
PMC: 7642255.
DOI: 10.3389/fimmu.2020.584099.
Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control: A case report.
Jin Y, Yang W, Zou S, Sun Z, Wu C, Yang Z
Medicine (Baltimore). 2020; 99(43):e22785.
PMID: 33120792
PMC: 7581140.
DOI: 10.1097/MD.0000000000022785.
Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation.
Gao F, Ye Y, Gao Y, Huang H, Zhao Y
Front Immunol. 2020; 11:2022.
PMID: 32983145
PMC: 7493622.
DOI: 10.3389/fimmu.2020.02022.
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
Zaghi E, Calvi M, Di Vito C, Mavilio D
Front Immunol. 2019; 10:2794.
PMID: 31849972
PMC: 6892976.
DOI: 10.3389/fimmu.2019.02794.
Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer.
Nersesian S, Glazebrook H, Toulany J, Grantham S, Boudreau J
Front Immunol. 2019; 10:1782.
PMID: 31456796
PMC: 6699519.
DOI: 10.3389/fimmu.2019.01782.
The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction.
Market M, Baxter K, Angka L, Kennedy M, Auer R
Cancers (Basel). 2018; 11(1).
PMID: 30577463
PMC: 6356325.
DOI: 10.3390/cancers11010002.
Natural Killer Cells - Their Role in Tumour Immunosurveillance.
Sharma P, Kumar P, Sharma R
J Clin Diagn Res. 2017; 11(8):BE01-BE05.
PMID: 28969116
PMC: 5620756.
DOI: 10.7860/JCDR/2017/26748.10469.
Reconstitution of multifunctional CD56CD16 natural killer cell subset in children with acute leukemia given α/β T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation.
Stabile H, Nisti P, Peruzzi G, Fionda C, Pagliara D, Brescia P
Oncoimmunology. 2017; 6(9):e1342024.
PMID: 28932646
PMC: 5599095.
DOI: 10.1080/2162402X.2017.1342024.
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de....
Nguyen S, Achour A, Souchet L, Vigouroux S, Chevallier P, Furst S
Bone Marrow Transplant. 2017; 52(10):1428-1435.
PMID: 28650455
DOI: 10.1038/bmt.2017.122.
Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.
Sarvaria A, Jawdat D, Madrigal J, Saudemont A
Front Immunol. 2017; 8:329.
PMID: 28386260
PMC: 5362597.
DOI: 10.3389/fimmu.2017.00329.
GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
Bunting M, Varelias A, Souza-Fonseca-Guimaraes F, Schuster I, Lineburg K, Kuns R
Blood. 2016; 129(5):630-642.
PMID: 27927647
PMC: 5290987.
DOI: 10.1182/blood-2016-08-734020.
Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation.
Ullah M, Hill G, Tey S
Front Immunol. 2016; 7:144.
PMID: 27148263
PMC: 4831973.
DOI: 10.3389/fimmu.2016.00144.
Cord Blood as a Source of Natural Killer Cells.
Mehta R, Shpall E, Rezvani K
Front Med (Lausanne). 2016; 2:93.
PMID: 26779484
PMC: 4700256.
DOI: 10.3389/fmed.2015.00093.
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
Dahlberg C, Sarhan D, Chrobok M, Duru A, Alici E
Front Immunol. 2015; 6:605.
PMID: 26648934
PMC: 4663254.
DOI: 10.3389/fimmu.2015.00605.
Matrine regulates immune functions to inhibit the proliferation of leukemic cells.
Zhang L, Zhang H, Zhu Z, Jiang L, Lu X, Zhou M
Int J Clin Exp Med. 2015; 8(4):5591-600.
PMID: 26131142
PMC: 4484016.
Clinical utility of natural killer cells in cancer therapy and transplantation.
Knorr D, Bachanova V, Verneris M, Miller J
Semin Immunol. 2014; 26(2):161-72.
PMID: 24618042
PMC: 3984606.
DOI: 10.1016/j.smim.2014.02.002.